IPHAInnate Pharma SA

NASDAQ · Biological Products, (No Diagnostic Substances)

Last close $1.63 · 2026-09-30

ABOUT

ExchangeNASDAQ

SectorHealthcare

IndustryBiological Products, (No Diagnostic Substances)

INSTITUTIONAL OWNERSHIP

Institutional holders10

Shares held192,418

Value$354.05K

As of quarter end2026-06-30

RECENT NEWS

Innate Pharma (IPHA) Closes Sobi Deal. Can the New Funding Keep Drug Trials on Track?
Innate Pharma reports 2026 Q2 results
Innate Pharma stock maintained at Buy by H.C. Wainwright
Sobi and Innate partnership becomes effective after closing conditions met

CatalystPit

2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS